Profess Study: Prevention Regimen For Effectively avoiding Second Strokes
Enrollment is limited to male or female patients at least 55 years of age with an ischemic stroke who are neurologically and clinically stable. The qualifying stroke must be within 90 days of entry into the study.

Migraine Therapy Evaluation Protocol (MTEP)
Patients will participate in the study for the duration of 3 months or for 2 migraine attacks. Patients must be 18 years of age, diagnosed as having migraine headaches with or with aura, recently experienced 1 or more attacks per month, not previously treated with Maxalt, and has had an oral medication prescribed for the acute treatment of migraine attacks.

SAINT II (Stroke – Acute Ischemic – NXY Treatment)
Patients will be admitted to the study at the onset of stroke within 6 hours and followed for 90 days post stroke. Patients must be 18 years of age and have a clinical diagnosis of acute ischemic stroke with limb weakness as part of the presenting deficits.

The Clinic is often looking for volunteers to participate in its clinical trials. Please inform your physician of your interest or contact our Clinical Research Director, Helen Neil, BSN, R.N. You can phone her at 504-349-6976 ex. 4707 or email her at hneil@culicchianeuro.com to learn about ongoing studies and qualifications for volunteers.